Cathay Biotech Inc (688065) — Cash Flow Reinvestment Rate
Cathay Biotech Inc (688065) has a Cash Flow Reinvestment Rate of 0.31x as of June 2025, reinvesting CN¥78.51 Million (capex CN¥78.51 Million ) from operating cash flow of CN¥251.82 Million. See how much free cash does Cathay Biotech Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cathay Biotech Inc Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Cathay Biotech Inc across 8 annual periods. For the full cash flow conversion analysis, see 688065 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Cathay Biotech Inc (2017–2025)
Year-by-year capital reinvestment analysis for Cathay Biotech Inc. See 688065 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.87x | CN¥755.33 Million | CN¥404.12 Million | CN¥743.46 Million | ▼ -7.9% |
| 2024 | 2.03x | CN¥1.67 Billion | CN¥820.93 Million | CN¥843.31 Million | ▼ -63.1% |
| 2023 | 5.49x | CN¥3.13 Billion | CN¥569.45 Million | CN¥1.57 Billion | ▼ -47.4% |
| 2022 | 10.45x | CN¥8.40 Billion | CN¥803.67 Million | CN¥4.20 Billion | ▲ +287.8% |
| 2021 | 2.69x | CN¥1.60 Billion | CN¥594.18 Million | CN¥1.47 Billion | ▼ -29.2% |
| 2020 | 3.81x | CN¥1.96 Billion | CN¥514.96 Million | CN¥763.11 Million | ▼ -20.3% |
| 2019 | 4.78x | CN¥1.72 Billion | CN¥359.62 Million | CN¥511.14 Million | ▼ -74.3% |
| 2017 | 18.62x | CN¥995.09 Million | CN¥53.45 Million | CN¥995.09 Million | — |